Asia Pharma R&D Leaders in Shanghai

26.02.2025 - 27.02.2025

2025 APRL The 13th
Asia Pharma R&D Leaders

Crossing Cycle - Integrating Innovation - Empowering Clinical

In recent years, global investment in drug research and development has continued to grow. In the fierce competition in the market, the only way to meet the needs of patients is to continuously launch innovative drugs. With the increase in the number of players entering the market, the competition is becoming more and more intense. The continuous progress of drug R&D in the international market and changes in regulatory and approval requirements have put forward higher requirements for the innovative drug R&D capability, clinical trial design capability, and domestic and international clinical trial promotion capability of domestic pharmaceutical companies. In order to meet the medical needs of patients early and reduce the cost of new drug development, it is a major challenge for innovative drug R&D companies to formulate reasonable development strategies at different stages of innovative drug R&D, and accelerate the translation of early clinical trial results into late-stage clinical trials as soon as possible. What innovations will be the catalysts for clinical breakthroughs? How should the industry build collaborative networks to advance clinical research in a more effective way? How to develop an early strategy to build a bridge connecting preclinical and late-stage development, empowering the preclinical research stage and clinical development, and improving the clinical success rate are also the key points that drug companies need to think about nowadays.

Based on this, the 13th APRL Asia Pharmaceutical R&D Leadership Summit will be held on February 26-27, 2025 in Shanghai with the theme of “Crossing Cycle, Integrating Innovation, Empowering Clinical” . Based on the success of the previous twelve sessions, this conference will once again bring together 70+ pharmaceutical R&D leaders and 1200+ industry colleagues to gather in Shanghai to explore differentiated R&D strategies, empower preclinical research and clinical development, improve clinical development efficiency, innovate collaborative development models, and enable innovation to truly empower the clinic!

Conference Highlights

Gathering global pharmaceutical R&D leaders and experts to talk about the new pattern of drug R&D strategy
Depth analysis of drug early clinical research, build a bridge between preclinical and late-stage development
Focus on the formulation of clinical development strategy, explore the international clinical strategy and global layout
Locking the industry's cutting-edge hot R&D direction, sharing the new results of drug R & D breakthroughs

More information